HSBC’s Strategy for India:
– FII inflows into Indian equities reached $21 billion by the end of 2023, with expectations for further growth. Target remains optimistic.
– Large caps are poised for growth due to strong FII inflows, offering a favorable risk-reward profile. Target growth expected.
– Financials are highlighted for their growth potential at attractive valuations. Target valuations look promising.
– A risk-on stance may favor sectors like IT in 2024, given their underperformance in 2023. IT sector target remains under observation.
– HSBC favors India over its regional peers, particularly banks, healthcare, and energy. Target set higher for these sectors.
Jefferies’ Real Estate Outlook:
– Mindspace REIT’s rating is upgraded to “Buy” with a target price of Rs 365.
– Prestige is downgraded to “Underperform” but sees an increased target price of Rs 1,000.
– Sobha’s rating shifts to “Hold” with a target price of Rs 1,265.
– DLF is recommended as a “Buy” with a target price of Rs 875.
– Godrej Prop remains a “Buy” with a new target of Rs 2,635.
– Oberoi Realty is suggested as “Hold” with a target of Rs 1,375.
– Macrotech maintains a “Buy” stance with a target price of Rs 1,290.
– Embassy REIT is retained as “Buy” with a target of Rs 394.
– Sunteck Realty remains a “Buy” with a target price of Rs 555.
Emkay on Zee Entertainment:
– Sony India appears set to withdraw from the merger with Zee Entertainment by 20-Jan-24. Zee’s target price may be impacted.
– Potential merger breakdown could affect both Sony and Zee negatively, given their past growth trends. Targets revised downward due to uncertainty.
– A final decision on the merger is expected soon. If canceled, Zee’s stock could see a significant drop.
JPMorgan on Tata Motors:
– JPMorgan maintains an “Overweight” stance on Tata Motors with a target price of Rs 925.
– Sales trends are positive, but North America lags. Targets are set with cautious optimism.
– Q3 forecasts indicate strong profitability across JLR and India businesses, with targets reflecting this optimism.
– Management’s approach to free cash flow and debt reduction will be closely watched, potentially impacting the stock’s target price.
Jefferies’ on Financials Stock
– Nippon AMC: Maintained as a “Buy” with a target price raised to Rs 540 from Rs 440.
– HDFC AMC: Retained as a “Buy” with a target price increased to Rs 3,890 from Rs 3,230.
– KFin Tech: Kept at “Buy” with a target price elevated to Rs 660 from Rs 570.
– Max Financial: Maintained as “Buy” with a target price adjusted to Rs 1,200 from Rs 1,070.
– BSE: Remains a “Buy” with a target price set at Rs 3,000, up from Rs 2,700.
– Life Insurers: Steady growth observed but with concerns over weaker margins. Targets set with caution.
– General Insurers: Positioned well in the market, with target prices indicating positive growth prospects.
– Fintechs: Seen as potential rebound stories, with target prices reflecting optimistic recovery.
– Asset Managers: Benefiting from favorable market conditions, with target prices set at higher levels.
– Exchanges: Capitalizing on market digitization trends, with target prices reflecting growth opportunities.
Morgan Stanley’s Insights on Q4 Earnings:
– Profit growth driven by margin improvements.
– Domestically-focused sectors lead in broad growth.
– Anticipate 60% of Morgan Stanley’s coverage to see margin growth.
– Expect subdued top-line expansion.
– India remains within a positive earnings cycle.
– Preference for financials, consumer discretionary, and industrials; caution towards sectors reliant on external markets.
– Predict 8% revenue growth and 11% net profit growth for Sensex in Q3FY24.
– Nifty projected at 5% revenue growth and 12% net profit growth for the same period.
Citi Research on India’s Mutual Funds Sector:
– December 2023 records equity inflows of Rs 17,000 crore, sustaining growth.
– Anticipate a notable decline in lumpsum net flows compared to the last four months.
– Anticipated rise in NFOs might reduce inflows into current schemes.
Citi Research on Page Industries:
– Target set at 35,400.
– Concerns over near-term revenue and profitability.
– Challenges in athleisure and active wear demand.
– MBO expansion rate decelerating, particularly in kids wear.
– Potential strategy shifts due to recent management alterations.
Citi Research on Bata:
– Target set at 1340.
– Revenue and profitability at risk due to a sluggish discretionary demand environment.
– Slowing expansion of stores and distribution.
– Potential de-rating due to revenue growth lagging peers.
Jefferies on India’s Agribusiness Sector:
– ‘Buy’ recommendation for PI Industries with a target of Rs 4,290.
– SRF downgraded to ‘Underperform’ with a target of Rs 2,140.
– Neutral stance on Navin Fluorine, awaiting new Managing Director’s impact.
– Predicted lag in SRF business recovery despite recent stock performance.
– Growth expected to revert to historical averages by the end of CY24.
HSBC on Nykaa:
– Target price set at 250.
– Nykaa poised to leverage its scale and leadership in the BPC sector.
– Predicted CAGR of 20-30% for the BPC e-commerce market over the next decade.
– Revenue projected to double biennially over the subsequent five years.
Morgan Stanley on India’s Auto, Airlines, and Hospitals:
– Auto sector nearing peak volume growth.
– Top preferences: Tata Motors, Ashok Leyland, Mahindra, Maruti, Bajaj Auto.
– In airlines, Interglobe Aviation (Indigo) stands out due to industry consolidation.
– Indian healthcare sector has untapped potential in infrastructure and medical expenditure.
– Apollo hospitals focusing on capex, growth, and margin enhancement.
Sector-wise Q3 Results Preview:
– Nirmal Bang: Chemicals – Revival potential, but timing uncertain.
– Prabhudas Lilladher: Oil & Gas – Anticipate subdued operating outcomes.
– Prabhudas Lilladher: Travel & Tourism – Modest demand for luggage but optimistic about hotels.
– ICICI Securities: Automobiles – Earnings growth catalysts waning.
– Motilal Oswal: Q3 FY24 – Domestic cyclical sectors expected to boost earnings.
– Prabhudas Lilladher: Banks – Sequential decline in core profitability anticipated.
– ICICI Securities: Metals – Positive for miners, but ferrous segment drags.
– Prabhudas Lilladher: Healthcare – Pharma set for robust Ebitda growth, especially in U.S. markets.
Bringing you the latest updates on finance, economies, stocks, bonds, and more. Stay informed with timely insights.
Be First to Comment